Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Turcot syndrome 1Carcinoma, Ovarian Epithelial 1

Interventions

Specimen Handling 74Magnetic Resonance Spectroscopy 73Cyclophosphamide 69pembrolizumab 57Nivolumab 49Radiotherapy 48fludarabine 41Cisplatin 39Standard of Care 34Carboplatin 33Biopsy 33Bevacizumab 29Dexamethasone 28Rituximab 25Radiation 25Temozolomide 24Surveys and Questionnaires 24Radiosurgery 24Practice Guidelines as Topic 24Gemcitabine 24Doxorubicin 24Blood Specimen Collection 24venetoclax 23Cytarabine 23fludarabine phosphate 22Paclitaxel 21atezolizumab 20Ipilimumab 20Interviews as Topic 19Fluorouracil 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × denileukin diftitox × 30 days × Clear all
NCT05200559 2026-05-29

T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid Tumors

University of Pittsburgh

Phase 1/2 Active not recruiting
25 enrolled
Gynecologic

Turcot syndrome, Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡